Compass Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Compass Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,237	Closed	-$236K	–	85
2025 Q3	$236K	Buy	+5,237	New	+$245K	0.05%	141
2025 Q2	–	Sell	-3,698	Closed	-$226K	–	183
2025 Q1	$226K	Buy	3,698 +1,500	+68%	+$87.4K	0.06%	144
2024 Q4	$124K	Hold	2,198	–	–	0.03%	180
2024 Q3	$114K	Sell	2,198 -3,632	-62%	-$170K	0.03%	191
2024 Q2	$242K	Sell	5,830 -1,832	-24%	-$82K	0.06%	149
2024 Q1	$416K	Sell	7,662 -5,460	-42%	-$278K	0.1%	120
2023 Q4	$673K	Sell	13,122 -10,931	-45%	-$574K	0.19%	100
2023 Q3	$1.4M	Sell	24,053 -467	-2%	-$28.6K	0.44%	72
2023 Q2	$1.57M	Sell	24,520 -500	-2%	-$33.5K	0.47%	67
2023 Q1	$1.73M	Sell	25,020 -914	-4%	-$64.5K	0.55%	63
2022 Q4	$1.87M	Buy	+25,934	New	+$1.96M	0.61%	58

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Compass Wealth Management's BMY Position: Q4 2025 in Review

Compass Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 5,237 shares — an estimated $236K sold.

Compass Wealth Management first reported a position in BMY in Q4 2022 and held it in 11 quarters. The position peaked at $1.87M in Q4 2022. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

Compass Wealth Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
Compass Wealth Management sold 5,237 Bristol-Myers Squibb shares in Q4 2025, an estimated $236K.
Compass Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 11 quarters.
Compass Wealth Management's Bristol-Myers Squibb position peaked at $1.87M in Q4 2022.
2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Compass Wealth Management's 13F filing for Q4 2025, filed 11 Feb 2026.